| Literature DB >> 29480581 |
Ana Gutiérrez-Rodríguez1,2, Itziar Bonilla-Del Río1,2, Nagore Puente1,2, Sonia M Gómez-Urquijo1,2, Christine J Fontaine3, Jon Egaña-Huguet1,2, Izaskun Elezgarai1,2, Sabine Ruehle4, Beat Lutz4, Laurie M Robin5,6, Edgar Soria-Gómez1,2, Luigi Bellocchio5,6, Jalindar D Padwal7, Mario van der Stelt7, Juan Mendizabal-Zubiaga1,2, Leire Reguero1,2, Almudena Ramos1,2, Inmaculada Gerrikagoitia1,2, Giovanni Marsicano5,6, Pedro Grandes1,2,3.
Abstract
Astroglial type-1 cannabinoid (CB1 ) receptors are involved in synaptic transmission, plasticity and behavior by interfering with the so-called tripartite synapse formed by pre- and post-synaptic neuronal elements and surrounding astrocyte processes. However, little is known concerning the subcellular distribution of astroglial CB1 receptors. In particular, brain CB1 receptors are mostly localized at cells' plasmalemma, but recent evidence indicates their functional presence in mitochondrial membranes. Whether CB1 receptors are present in astroglial mitochondria has remained unknown. To investigate this issue, we included conditional knock-out mice lacking astroglial CB1 receptor expression specifically in glial fibrillary acidic protein (GFAP)-containing astrocytes (GFAP-CB1 -KO mice) and also generated genetic rescue mice to re-express CB1 receptors exclusively in astrocytes (GFAP-CB1 -RS). To better identify astroglial structures by immunoelectron microscopy, global CB1 knock-out (CB1 -KO) mice and wild-type (CB1 -WT) littermates were intra-hippocampally injected with an adeno-associated virus expressing humanized renilla green fluorescent protein (hrGFP) under the control of human GFAP promoter to generate GFAPhrGFP-CB1 -KO and -WT mice, respectively. Furthermore, double immunogold (for CB1 ) and immunoperoxidase (for GFAP or hrGFP) revealed that CB1 receptors are present in astroglial mitochondria from different hippocampal regions of CB1 -WT, GFAP-CB1 -RS and GFAPhrGFP-CB1 -WT mice. Only non-specific gold particles were detected in mouse hippocampi lacking CB1 receptors. Altogether, we demonstrated the existence of a precise molecular architecture of the CB1 receptor in astrocytes that will have to be taken into account in evaluating the functional activity of cannabinergic signaling at the tripartite synapse.Entities:
Keywords: cannabinoids; glia; immunoelectron microscopy; intracellular receptors; mitochondria; tripartite synapse
Mesh:
Substances:
Year: 2018 PMID: 29480581 DOI: 10.1002/glia.23314
Source DB: PubMed Journal: Glia ISSN: 0894-1491 Impact factor: 7.452